Decision aid for lymph node biopsy in melanoma
Part of Cancer, Skin clinical trials.
This study tests a decision aid to help people with intermediate-risk melanoma decide whether to have a sentinel lymph node biopsy. It aims to make the choice clearer and more informed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have melanoma that is stage I or II and your doctor is considering a sentinel lymph node biopsy.
- Your risk of cancer spreading to a lymph node is between 5 and 10 percent, or your risk estimate from a special calculator differs from what your doctor might expect.
- You are willing to follow study procedures and give consent.
- You can speak and read English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking a new way to find and remove lymph nodes that may contain cancer when there are only one or two affected nodes. The goal is to see if this method works well and to help guide further treatment.
This trial is testing if a less invasive sentinel lymph node biopsy can replace more extensive lymph node removal in women with inflammatory breast cancer who have had chemotherapy and whose nodes appear cancer-free. This could help avoid unnecessary side effects.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This trial tests if a specific type of lymph node surgery, combined with a short course of immunotherapy (medicines that help your immune system fight cancer), works better for melanoma that has spread to nearby lymph nodes. It's for people whose melanoma can be removed and who are healthy enough for treatment.
This trial tests whether removing a clinically involved lymph node basin (via a specific lymph node excision surgery) after certain melanoma findings is helpful. It mainly aims to see effects on outcomes and on arm/leg swelling (lymphedema) after surgery.
This trial tests whether patients with stage 3 melanoma that shrinks significantly after initial immunotherapy can safely avoid having all their lymph nodes surgically removed. Instead, only the main affected node is removed for testing.
Hear when a new Sentinel Lymph Node Biopsy (SLNB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.